Current issues in biowaivers and biosimilars

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2012 English Publisher:Informa UK LimitedJournal:Expert Review of Clinical Pharmacology, volume 6, pages 139-142 (issn: 1751-2433, eissn: 1751-2441,

Copyright policy )

Authors: Laszlo Endrenyi;

doi: 10.1586/ecp.12.72 , 10.4172/2161-1459.1000e117

Current issues in biowaivers and biosimilars

- Summary
- Metrics

Abstract

International Conference on Biowaivers and BiosimilarsSan Antonio, TX, USA, 10–12 September 2012An International Conference on Biowaivers and Biosimilars was held in San Antonio (TX, USA) on September 10–12, 2012. The conference was organized by OMICS Group Inc. The topics covered wide-ranging issues that are especially relevant to the current considerations of biosimilarity. Speakers came from North America and Europe, as well as from Argentina, Brazil, India and Israel.

Related Organizations

University of Toronto
Canada

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average